Skip to content
Recall Observatory FDA recall evidence

Drug product

LOSARTAN POTASSIUM 50 mg TABLET BULK 90 count bottles and 1000 count bottles, NDC 00591-3746-00

D-1455-2019

June 06, 2019

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 83050
Status
Ongoing
Classification
Class II
Quantity
2,924,000 tablets
Official record key
drug-enforcement:D-1455-2019

Official wording

Reason: CGMP Deviations: impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA) detected in the active pharmaceutical ingredient (API) used to manufacture finished products.

Code information: Arrow Malta (Teva) Bulk Product Lot # 1169752A, exp. date 01/2020, 1000 tablets/bottle 1169753A, exp. date 01/2020, 90 tablets/bottle Golden State Medical Finished Product Lot # GS017387, exp. date 01/2020 GS017651, exp. date 01/2020 GS017479, exp. date 01/2020

Distribution pattern: Nationwide by 4 major distributors.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity for N-Nitroso-N-methyl-4-aminobutyric acid (NMBA
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations